At the time of writing, LifeStance Health Group Inc [LFST] stock is trading at $4.22, down -4.52%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LFST shares have lost -6.43% over the last week, with a monthly amount drifted -16.27%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
LifeStance Health Group Inc [NASDAQ: LFST] stock has seen the most recent analyst activity on May 27, 2025, when UBS upgraded its rating to a Buy but kept the price target unchanged to $8.50 for it. Previously, KeyBanc Capital Markets started tracking the stock with Overweight rating on April 08, 2025, and set its price target to $9. On April 03, 2025, Canaccord Genuity initiated with a Buy rating and assigned a price target of $8 on the stock. Goldman upgraded its rating to a Buy but stick to its price target of $10 on December 16, 2024. Barclays initiated its recommendation with a Underweight and recommended $7 as its price target on January 03, 2024. TD Cowen downgraded its rating to Market Perform for this stock on May 15, 2023, and upped its price target to $9. In a note dated January 06, 2023, Morgan Stanley upgraded an Overweight rating on this stock but restated the target price of $8.
For the past year, the stock price of LifeStance Health Group Inc fluctuated between $4.33 and $8.61. Currently, Wall Street analysts expect the stock to reach $8.5 within the next 12 months. LifeStance Health Group Inc [NASDAQ: LFST] shares were valued at $4.22 at the most recent close of the market. An investor can expect a potential return of 101.42% based on the average LFST price forecast.
Analyzing the LFST fundamentals
According to LifeStance Health Group Inc [NASDAQ:LFST], the company’s sales were 1.28B for trailing twelve months, which represents an 10.83% jump. Gross Profit Margin for this corporation currently stands at 0.3% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.03%, and Net Profit Margin reading is -0.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.02 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.14 points at the first support level, and at 4.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.37, and for the 2nd resistance point, it is at 4.53.
Ratios To Look Out For
It is important to note that LifeStance Health Group Inc [NASDAQ:LFST] has a current ratio of 1.47. Further, the Quick Ratio stands at 1.47, while the Cash Ratio is 0.65. Considering the valuation of this stock, the price to sales ratio is 1.28, the price to book ratio is 1.13.
Transactions by insiders
Recent insider trading involved Ramtekkar Ujjwal, Chief Medical Officer, that happened on Jun 16 ’25 when 9519.0 shares were sold. Officer, Ramtekkar Ujjwal completed a deal on Jun 16 ’25 to buy 9519.0 shares. Meanwhile, Chief Medical Officer Ramtekkar Ujjwal sold 16000.0 shares on Jun 05 ’25.
